vs

Side-by-side financial comparison of HERITAGE COMMERCE CORP (HTBK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $53.6M, roughly 1.4× HERITAGE COMMERCE CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 15.6%). HERITAGE COMMERCE CORP produced more free cash flow last quarter ($61.3M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 12.8%).

The United States Chamber of Commerce (USCC) is a business association advocacy group and is the largest lobbying group in the United States. The group was founded in April 23, 1912, out of local chambers of commerce at the urging of President William Howard Taft and his secretary of commerce and labor Charles Nagel. President Taft's belief was that the "government needed to deal with a group that could speak with authority for the interests of business."

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

HTBK vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.4× larger
PBYI
$75.5M
$53.6M
HTBK
Growing faster (revenue YoY)
PBYI
PBYI
+12.1% gap
PBYI
27.7%
15.6%
HTBK
More free cash flow
HTBK
HTBK
$46.9M more FCF
HTBK
$61.3M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
12.8%
HTBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTBK
HTBK
PBYI
PBYI
Revenue
$53.6M
$75.5M
Net Profit
$15.1M
Gross Margin
69.3%
Operating Margin
41.0%
22.7%
Net Margin
28.2%
Revenue YoY
15.6%
27.7%
Net Profit YoY
42.3%
EPS (diluted)
$0.25
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTBK
HTBK
PBYI
PBYI
Q4 25
$53.6M
$75.5M
Q3 25
$50.0M
$54.5M
Q2 25
$47.8M
$52.4M
Q1 25
$46.1M
$46.0M
Q4 24
$46.4M
$59.1M
Q3 24
$42.2M
$80.5M
Q2 24
$41.7M
$47.1M
Q1 24
$42.1M
$43.8M
Net Profit
HTBK
HTBK
PBYI
PBYI
Q4 25
$15.1M
Q3 25
$14.7M
$8.8M
Q2 25
$6.4M
$5.9M
Q1 25
$11.6M
$3.0M
Q4 24
$10.6M
Q3 24
$10.5M
$20.3M
Q2 24
$9.2M
$-4.5M
Q1 24
$10.2M
$-4.8M
Gross Margin
HTBK
HTBK
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
HTBK
HTBK
PBYI
PBYI
Q4 25
41.0%
22.7%
Q3 25
41.1%
17.6%
Q2 25
18.7%
12.7%
Q1 25
35.4%
8.7%
Q4 24
31.8%
22.6%
Q3 24
34.3%
27.4%
Q2 24
31.3%
-4.6%
Q1 24
34.2%
-5.3%
Net Margin
HTBK
HTBK
PBYI
PBYI
Q4 25
28.2%
Q3 25
29.4%
16.2%
Q2 25
13.4%
11.2%
Q1 25
25.2%
6.5%
Q4 24
22.9%
Q3 24
24.9%
25.2%
Q2 24
22.1%
-9.6%
Q1 24
24.1%
-11.0%
EPS (diluted)
HTBK
HTBK
PBYI
PBYI
Q4 25
$0.25
$0.26
Q3 25
$0.24
$0.17
Q2 25
$0.10
$0.12
Q1 25
$0.19
$0.06
Q4 24
$0.17
$0.40
Q3 24
$0.17
$0.41
Q2 24
$0.15
$-0.09
Q1 24
$0.17
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTBK
HTBK
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$708.6M
$130.3M
Total Assets
$5.8B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTBK
HTBK
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
HTBK
HTBK
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
HTBK
HTBK
PBYI
PBYI
Q4 25
$708.6M
$130.3M
Q3 25
$700.0M
$115.3M
Q2 25
$694.7M
$104.7M
Q1 25
$696.2M
$97.1M
Q4 24
$689.7M
$92.1M
Q3 24
$685.4M
$71.1M
Q2 24
$679.2M
$48.5M
Q1 24
$676.3M
$51.0M
Total Assets
HTBK
HTBK
PBYI
PBYI
Q4 25
$5.8B
$216.3M
Q3 25
$5.6B
$202.9M
Q2 25
$5.5B
$194.9M
Q1 25
$5.5B
$196.2M
Q4 24
$5.6B
$213.3M
Q3 24
$5.6B
$220.7M
Q2 24
$5.3B
$205.0M
Q1 24
$5.3B
$214.1M
Debt / Equity
HTBK
HTBK
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTBK
HTBK
PBYI
PBYI
Operating Cash FlowLast quarter
$61.7M
$14.4M
Free Cash FlowOCF − Capex
$61.3M
$14.4M
FCF MarginFCF / Revenue
114.3%
19.1%
Capex IntensityCapex / Revenue
0.7%
0.0%
Cash ConversionOCF / Net Profit
4.08×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTBK
HTBK
PBYI
PBYI
Q4 25
$61.7M
$14.4M
Q3 25
$18.9M
$9.7M
Q2 25
$8.0M
$14.1M
Q1 25
$14.8M
$3.6M
Q4 24
$39.0M
$15.6M
Q3 24
$5.3M
$11.0M
Q2 24
$10.5M
$1.0M
Q1 24
$7.3M
$11.2M
Free Cash Flow
HTBK
HTBK
PBYI
PBYI
Q4 25
$61.3M
$14.4M
Q3 25
$18.8M
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$37.3M
$15.6M
Q3 24
$4.9M
$11.0M
Q2 24
$9.9M
$1.0M
Q1 24
$6.9M
FCF Margin
HTBK
HTBK
PBYI
PBYI
Q4 25
114.3%
19.1%
Q3 25
37.7%
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
80.5%
26.4%
Q3 24
11.6%
13.7%
Q2 24
23.6%
2.1%
Q1 24
16.4%
Capex Intensity
HTBK
HTBK
PBYI
PBYI
Q4 25
0.7%
0.0%
Q3 25
0.1%
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
3.5%
0.0%
Q3 24
1.0%
0.0%
Q2 24
1.6%
0.0%
Q1 24
1.0%
0.0%
Cash Conversion
HTBK
HTBK
PBYI
PBYI
Q4 25
4.08×
Q3 25
1.28×
1.10×
Q2 25
1.25×
2.41×
Q1 25
1.28×
1.21×
Q4 24
3.67×
Q3 24
0.50×
0.54×
Q2 24
1.14×
Q1 24
0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons